--- title: Welcome to EirGenix’s Knowledge Platform (2) description: Are you looking for the latest information on developing and manufacturing biologics? We at EirGenix have the answers to help you learn; we share our knowledge, experience, and best practices. (2) --- ![Eirgenix Logo](https://resources.eirgenix.com/hubfs/Eirgenix%20Logo.jpg) - [ABOUT US](https://www.eirgenix.com/about-eirgenix) - [NEWS](https://www.eirgenix.com/eirgenix-news) - [CDMO SERVICES](https://www.eirgenix.com/services) - [PRODUCTS](https://www.eirgenix.com/products) - [BLOG](https://resources.eirgenix.com/blog) - [INVESTOR](https://www.eirgenix.com/financials) - [RECRUITING](https://www.104.com.tw/company/1a2x6bicyh) - [CONTACT US](https://www.eirgenix.com/contact-us) SIGN IN GET A DEMO [![Knowledge](https://resources.eirgenix.com/hs-fs/hubfs/Knowledge.jpg?width=500&height=281&name=Knowledge.jpg "Knowledge")](https://www.eirgenix.com) # Introducing EirGenix’s Blog Series on Drug Strategy and Development  ## Welcome to EirGenix’s Knowledge Platform **A New Blog Series for Biologic Drug Developers** The outbreak of diseases like COVID-19 and the growth of new treatments for diseases like cancer have highlighted the importance of cooperation between Biologic Developers and their contract manufacturing partners. For EirGenix, health is important for all people. Under this belief, EirGenix established our CDMO to help clients leverage our team's experience and knowledge in developing their biologics that we learned from developing biosimilars and biobetters. EirGenix's upholds the mission of providing clients with high-quality and cost-effective CDMO services and biologics. We do this to enhance the wellbeing of individuals and society, and improve the quality of life. Now more than ever, we need to foster education and dialogue to address the challenges and opportunities in drug development and commercialization.   **A complex and strategic partnership** Today, the relationship between Biologic Developers and CDMOs is more collaborative and strategic. As a strategic partner, we need to work closely with our clients to ensure product quality, cost efficiency, and regulatory compliance. At EirGenix, we understand the value of building strong and successful partnerships with our customers. We have the expertise, capabilities, and global operations to support their drug programs from development to launch. We also have the insights and ideas to help overcome the industry’s most pressing issues: to improve output, lower costs, speed up production, and provide better access.  We know that by working together we can help you achieve your goals. **Sharing our Knowledge and Expertise** To fulfill our mission, we are launching this knowledge platform – a new blog series where we will share our first-hand knowledge, experience, and best practices. This will be a place where you can learn from our team of experts, get inspired by our innovative solutions, and give you access to new science, capabilities, and ideas that will help you advance your drug programs. Thanks for your interest!   If you like what you see, please tell others! - [ALL](https://resources.eirgenix.com/blog/all) - [Monoclonal Antibody](https://resources.eirgenix.com/blog/tag/monoclonal-antibody) - [mAb](https://resources.eirgenix.com/blog/tag/mab) - [CHO-K1](https://resources.eirgenix.com/blog/tag/cho-k1) - [Cell Line Development](https://resources.eirgenix.com/blog/tag/cell-line-development) - [Method Development](https://resources.eirgenix.com/blog/tag/method-development) - [Process Development](https://resources.eirgenix.com/blog/tag/process-development) - [Antibody Drug Conjugate](https://resources.eirgenix.com/blog/tag/antibody-drug-conjugate) - [Method Qualification](https://resources.eirgenix.com/blog/tag/method-qualification) - [Method Validation](https://resources.eirgenix.com/blog/tag/method-validation) - [Partnership](https://resources.eirgenix.com/blog/tag/partnership) - [Tech Transfer](https://resources.eirgenix.com/blog/tag/tech-transfer) - [pDNA](https://resources.eirgenix.com/blog/tag/pdna) - [upstream development](https://resources.eirgenix.com/blog/tag/upstream-development) This is a search field with an auto-suggest feature attached. - There are no suggestions because the search field is empty. Cell Line Development ### [Guidelines for Choosing the Right mAb Cell Line - Part 2](https://resources.eirgenix.com/blog/guidelines-for-choosing-the-right-mab-cell-line-part2) Developing a mAb? Have you considered these cell line development factors? Let EirGenix’s experience and wisdom guide you towards success! EirGenix Staff Nov 15, 2023 Cell Line Development ### [Guidelines for Choosing the Right mAb Cell Line - Part 1](https://resources.eirgenix.com/blog/guidelines-for-choosing-the-right-mab-cell-line-part-1) Developing a mAb? Picking the right cell line is critical to your success. Make sure you review these factors! EirGenix Staff Oct 19, 2023 [1](https://resources.eirgenix.com/blog/page/1) [2](https://resources.eirgenix.com/blog/page/2) ## **Want to learn about our new articles?** ### Fill out the form below and receive notices by email.  ### Sign up for our Blog here [![computer](https://resources.eirgenix.com/hubfs/computer.webp "computer")](https://www.eirgenix.com/) ### Do you like what you read? Please let others know about us! Thank you for taking the time to read our article.  We hope you found it useful and informative! ![Eirgenix Logo-1](https://resources.eirgenix.com/hubfs/Eirgenix%20Logo-1.jpg) EirGenix upholds the mission of providing clients with high-quality and cost-effective CDMO services and biologics. We do this to enhance the well-being of individuals and society. ### Legal - [Sitemap](https://www.eirgenix.com/sitemap) - [Privacy Policy](https://www.eirgenix.com/privacy_policy) - [EIP](https://www.eirgenix.com/eip) copyright © 2023 EirGenix, Inc. all rights reserved. [Powered by Atlas - a B2B SaaS HubSpot theme](https://www.kalungi.com/atlas-hubspot-theme-for-b2b-saas-software)